Mid-market healthcare investor Ampersand raises $100m towards latest fund


Ampersand Capital Partners, a mid-market investor focusing on growth equity investments in the healthcare space, has raised over $100m towards its latest fund, according to a recent SEC filing.

Ampersand 2014 Limited Partnership has raised $102,832,308 to date. Atlantic-Pacific Capital and Harken Capital Securities are listed as placement agents for the vehicle, though no sales commission has yet been registered.

Over the past twenty years, Ampersand has raised seven funds, producing a 24 per cent pooled internal rate of return.

The fund has a final target of $300m, with a final close anticipate within the next six months, PEhub reported.

Last year the Boston-based private equity firm made three senior appointments to boost its management team, and also added a new operating partner to its roster.

The firm targets companies with revenues between $10m and $100m, typically investing between $10m and $50m per deal.

Copyright © 2014 AltAssets